{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06251973",
            "orgStudyIdInfo": {
                "id": "23-361"
            },
            "organization": {
                "fullName": "Memorial Sloan Kettering Cancer Center",
                "class": "OTHER"
            },
            "briefTitle": "A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer",
            "officialTitle": "A Phase II Study of agenT-797 (Invariant Natural Killer T Cells), Botensilimab, a Novel Fc-enhanced CTLA-4 Inhibitor, Plus Balstilimab (Anti-PD-1) With Ramucirumab and Paclitaxel for Patients With Previously Treated, Advanced Esophageal, Gastric, or Gastro-esophageal Junction Adenocarcinoma",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-study-of-agent-in-combination-with-botensilimab-balstilimab-ramucirumab-and-paclitaxel-for-people-with-esophageal-gastric-or-gastro-esophageal-junction-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "startDateStruct": {
                "date": "2024-02-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-08-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-08-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-02-01",
            "studyFirstSubmitQcDate": "2024-02-01",
            "studyFirstPostDateStruct": {
                "date": "2024-02-09",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-24",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-28",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Memorial Sloan Kettering Cancer Center",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Participants will receive study treatment with agenT-797, botensilimab, balstilimab, ramucirumab, and paclitaxel. When participants start each agent will depend on how their disease is affecting them."
        },
        "conditionsModule": {
            "conditions": [
                "Metastatic Esophageal Carcinoma",
                "Advanced Unresectable Gastric Adenocarcinoma",
                "Metastatic Gastric Cancer",
                "Metastatic Gastroesophageal Junction Adenocarcinoma",
                "Metastatic Esophageal Cancer",
                "Metastatic Esophageal Adenocarcinoma",
                "Metastatic Gastric Adenocarcinoma",
                "Metastatic Gastric Carcinoma",
                "Unresectable Esophageal Cancer",
                "Unresectable Esophageal Adenocarcinoma",
                "Unresectable Gastric Carcinoma",
                "Unresectable Gastric Adenocarcinoma",
                "Unresectable Gastroesophageal Junction Adenocarcinoma"
            ],
            "keywords": [
                "Metastatic Esophageal Carcinoma",
                "Advanced Unresectable Gastric Adenocarcinoma",
                "Metastatic Gastric Cancer",
                "Metastatic Gastroesophageal Junction Adenocarcinoma",
                "Metastatic Esophageal Cancer",
                "Metastatic Esophageal Adenocarcinoma",
                "Metastatic Gastric Adenocarcinoma",
                "Metastatic Gastric Carcinoma",
                "Unresectable Esophageal Cancer",
                "Unresectable Esophageal Adenocarcinoma",
                "Unresectable Gastric Carcinoma",
                "Unresectable Gastric Adenocarcinoma",
                "Unresectable Gastroesophageal Junction Adenocarcinoma",
                "23-261",
                "Memorial Sloan Kettering Cancer Center"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 38,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Participants diagnoses with Esophageal, Gastric, or Gastro-esophageal Junction Cancer",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with measurable disease and with evaluable disease as defined by RECIST v1.1 will be enrolled on this study.",
                    "interventionNames": [
                        "Biological: AgenT-797",
                        "Biological: Botensilimab",
                        "Drug: Balstilimab",
                        "Drug: Ramucirumab",
                        "Drug: Paclitaxel"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "AgenT-797",
                    "description": "AgenT-797 is an investigational product, composed of allogeneic human unmodified iNKT cells, isolated from mononuclear cell aphaeresis units from healthy donors",
                    "armGroupLabels": [
                        "Participants diagnoses with Esophageal, Gastric, or Gastro-esophageal Junction Cancer"
                    ]
                },
                {
                    "type": "BIOLOGICAL",
                    "name": "Botensilimab",
                    "description": "Botensilimab is a novel, human, Fc-engineered IgG1 anti-CTLA-4 antibody",
                    "armGroupLabels": [
                        "Participants diagnoses with Esophageal, Gastric, or Gastro-esophageal Junction Cancer"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Balstilimab",
                    "description": "Botensilimab is supplied as a sterile, single-use solution for IV administration",
                    "armGroupLabels": [
                        "Participants diagnoses with Esophageal, Gastric, or Gastro-esophageal Junction Cancer"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Ramucirumab",
                    "description": "Ramucirumab is a fully human anti-VEGFR2 monoclonal IgG1 antibody (IgG1) that binds with high affinity to the extracellular domain of VEGFR2. Ramucirumab is a part of standard of care treatment for advanced gastric cancer or GEJ adenocarcinoma, after prior treatment with fluoropyrimidine- or platinum-containing chemotherarapy.",
                    "armGroupLabels": [
                        "Participants diagnoses with Esophageal, Gastric, or Gastro-esophageal Junction Cancer"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Paclitaxel",
                    "description": "Paclitaxel is widely used across multiple cancer types and is a part of standard of care treatment for advanced EG adenocarcinoma after prior treatment with fluoropyrimidine- or platinum-containing chemotherarapy.",
                    "armGroupLabels": [
                        "Participants diagnoses with Esophageal, Gastric, or Gastro-esophageal Junction Cancer"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Overall Response Rate",
                    "description": "Determine the efficacy of agenT-797, botensilimab and balstilimab in combination with ramucirumab and paclitaxel as second-line therapy in patients with advanced unresectable or metastatic esophagogastric cancer, as measured by ORR (defined as the percentage of patients who achieve either an objective complete response \\[CR\\] + partial response \\[PR\\])",
                    "timeFrame": "up to 2 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Metastatic or advanced unresectable adenocarcinoma of esophageal, gastric, or gastroesophageal junction\n* Disease progression on one prior line of therapy for metastatic disease. Patients with previously untreated advanced unresectable or metastatic disease may be included if disease progressed or recurred during neoadjuvant or adjuvant therapy or within 6 months of completion of those treatments.\n* Patients must have histologically or cytologically confirmed esophageal, gastric, or gastroesophageal junction adenocarcinoma\n* Patients must have measurable or evaluable disease as defined by RECIST v1.1 criteria. Patients with evaluable disease must be eligible to begin with an induction cycle\n* Age 18 years or older\n* ECOG performance status 0 to 1\n* Adequate organ function as defined in Table 2\n\nTable 2. Organ function requirements for eligibility Hematological Absolute neutrophil count: \u22651000/mcL Platelets: \u226590,000/mcL Hemoglobin: \u22658 g/dL Renal Serum creatinine: \u22641.5X ULN Hepatic Serum total bilirubin: \u22641.5X ULN OR Direct bilirubin \u2264ULN for subjects with total bilirubin levels \\>1.5X ULN, except patients with Gilbert's disease (\u22643X ULN) AST and ALT: \u22642.5X ULN Albumin: \u22653 mg/dL\n\nExclusion Criteria:\n\n* Received prior therapy with ramucirumab at any time\n* Received paclitaxel or docetaxel-based therapy within 6 month of study enrollment\n* Had a prior grade \\>3 immune related adverse event due to anti-PD-1, anti-PD-L1, anti-PD-L2, or anti-CTLA4 therapy at any time\n* Diagnosis of immunodeficiency or receipt of systemic steroid therapy or any other form of immunosuppressive therapy within 7 days before the first dose of trial treatment. Replacement therapy (ie physiologic corticosteroid replacement therapy for adrenal or pituitary insufficiency) is not considered a form of systemic immunosuppressive therapy and is allowed.\n* History of gastrointestinal perforation or fistulae\n* A known history of active Bacillus tuberculosis\n* Known active central nervous system metastases and/or carcinomatous meningitis\n* History of or any evidence of active, non-infectious pneumonitis\n* Peripheral neuropathy limiting ADLs\n* A known history of human immunodeficiency virus (HIV 1/2 antibodies)\n* Known active hepatitis B (e.g., HBsAg reactive) or hepatitis C (e.g., HCV RNA \\[qualitative\\] is detected). Patients with HBsAg reactive on entecavir may be eligible after consultation with hepatologist and study team.\n* Received a live vaccine within 30 days of planned start of study therapy\n* Known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial\n* Pregnant or breastfeeding or expecting to conceive or father children within the projected duration of the trial, starting with the prescreening or screening visit through 5 months after the last dose of trial treatment\n* Unwilling to give written, informed consent, unwilling to participate, or unable to comply with the protocol for the duration of the study",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Yelena Janjigian, MD",
                    "role": "CONTACT",
                    "phone": "646-888-4186",
                    "email": "janjigiy@mskcc.org"
                },
                {
                    "name": "Geoffrey Ku, MD",
                    "role": "CONTACT",
                    "phone": "646-888-4588",
                    "email": "kug@mskcc.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Yelena Janjigian, MD",
                    "affiliation": "Memorial Sloan Kettering Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)",
                    "status": "RECRUITING",
                    "city": "Basking Ridge",
                    "state": "New Jersey",
                    "zip": "07920",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Yelena Janjigian, MD",
                            "role": "CONTACT",
                            "phone": "646-888-4186"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.70621,
                        "lon": -74.54932
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Monmouth (Limited Protocol Activities)",
                    "status": "RECRUITING",
                    "city": "Middletown",
                    "state": "New Jersey",
                    "zip": "07748",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Yelena Janjigian, MD",
                            "role": "CONTACT",
                            "phone": "646-888-4186"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.39652,
                        "lon": -74.09211
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Bergen (Limited Protocol Activities)",
                    "status": "RECRUITING",
                    "city": "Montvale",
                    "state": "New Jersey",
                    "zip": "07645",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Yelena Janjigian, MD",
                            "role": "CONTACT",
                            "phone": "646-888-4186"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.04676,
                        "lon": -74.02292
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Suffolk-Commack (Limited protocol activities)",
                    "status": "RECRUITING",
                    "city": "Commack",
                    "state": "New York",
                    "zip": "11725",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Yelena Janjigian, MD",
                            "role": "CONTACT",
                            "phone": "646-888-4186"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.84288,
                        "lon": -73.29289
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Westchester (Limited Protocol Activities)",
                    "status": "RECRUITING",
                    "city": "Harrison",
                    "state": "New York",
                    "zip": "10604",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Yelena Janjigian, MD",
                            "role": "CONTACT",
                            "phone": "646-888-4186"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.96899,
                        "lon": -73.71263
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Cancer Center (All Protocol Activities)",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Yelena Y Janjigian, MD",
                            "role": "CONTACT",
                            "phone": "646-888-4186"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Nassau (Limited Protocol Activities)",
                    "status": "RECRUITING",
                    "city": "Uniondale",
                    "state": "New York",
                    "zip": "11553",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Yelena Janjigian, MD",
                            "role": "CONTACT",
                            "phone": "646-888-4186"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.70038,
                        "lon": -73.59291
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Memorial Sloan Kettering Cancer Center",
                    "url": "http://www.mskcc.org"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Memorial Sloan Kettering Cancer Center supports the international committee of medical journal editors (ICMJE) and the ethical obligation of responsible sharing of data from clinical trials. The protocol summary, a statistical summary, and informed consent form will be made available on clinicaltrials.gov when required as a condition of Federal awards, other agreements supporting the research and/or as otherwise required. Requests for deidentified individual participant data can be made beginning 12 months after publication and for up to 36 months post publication. Deidentified individual participant data reported in the manuscript will be shared under the terms of a Data Use Agreement and may only be used for approved proposals. Requests may be made to: crdatashare@mskcc.org."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000000230",
                    "term": "Adenocarcinoma"
                },
                {
                    "id": "D000013274",
                    "term": "Stomach Neoplasms"
                },
                {
                    "id": "D000004938",
                    "term": "Esophageal Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000005770",
                    "term": "Gastrointestinal Neoplasms"
                },
                {
                    "id": "D000004067",
                    "term": "Digestive System Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                },
                {
                    "id": "D000013272",
                    "term": "Stomach Diseases"
                },
                {
                    "id": "D000006258",
                    "term": "Head and Neck Neoplasms"
                },
                {
                    "id": "D000004935",
                    "term": "Esophageal Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3585",
                    "name": "Adenocarcinoma",
                    "asFound": "Adenocarcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "asFound": "Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M16064",
                    "name": "Stomach Neoplasms",
                    "asFound": "Gastric Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8088",
                    "name": "Esophageal Neoplasms",
                    "asFound": "Esophageal Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M7256",
                    "name": "Digestive System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8886",
                    "name": "Gastrointestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M16062",
                    "name": "Stomach Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9348",
                    "name": "Head and Neck Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8085",
                    "name": "Esophageal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T5486",
                    "name": "Stomach Cancer",
                    "asFound": "Gastric Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2141",
                    "name": "Esophageal Cancer",
                    "asFound": "Esophageal Cancer",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000017239",
                    "term": "Paclitaxel"
                },
                {
                    "id": "D000096662",
                    "term": "Ramucirumab"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000972",
                    "term": "Antineoplastic Agents, Phytogenic"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000050257",
                    "term": "Tubulin Modulators"
                },
                {
                    "id": "D000050256",
                    "term": "Antimitotic Agents"
                },
                {
                    "id": "D000050258",
                    "term": "Mitosis Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000020533",
                    "term": "Angiogenesis Inhibitors"
                },
                {
                    "id": "D000043924",
                    "term": "Angiogenesis Modulating Agents"
                },
                {
                    "id": "D000006133",
                    "term": "Growth Substances"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000006131",
                    "term": "Growth Inhibitors"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4225",
                    "name": "Antibodies",
                    "relevance": "LOW"
                },
                {
                    "id": "M19537",
                    "name": "Paclitaxel",
                    "asFound": "Sessions",
                    "relevance": "HIGH"
                },
                {
                    "id": "M231",
                    "name": "Albumin-Bound Paclitaxel",
                    "relevance": "LOW"
                },
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M10184",
                    "name": "Immunoglobulins",
                    "relevance": "LOW"
                },
                {
                    "id": "M3246",
                    "name": "Ramucirumab",
                    "asFound": "Seed",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26197",
                    "name": "Tubulin Modulators",
                    "relevance": "LOW"
                },
                {
                    "id": "M26196",
                    "name": "Antimitotic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M22318",
                    "name": "Angiogenesis Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M9231",
                    "name": "Growth Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                }
            ]
        }
    },
    "hasResults": false
}